313 related articles for article (PubMed ID: 35624326)
1. Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
Kumar A; Shenoy V; Buckley MC; Durbin L; Mackey J; Mone A; Swaminath A
Dig Dis Sci; 2022 Oct; 67(10):4851-4865. PubMed ID: 35624326
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 4 L, 2 L, and 1 L PEG bowel preparation for colonoscopy in patients with ulcerative colitis: a retrospective study.
Dai C; Tian W; Huang YH; Jiang M
Rev Esp Enferm Dig; 2023 Oct; ():. PubMed ID: 37882178
[TBL] [Abstract][Full Text] [Related]
3. Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials.
Shehab M; Alrashed F; Alkazemi A; Lakatos PL; Bessissow T
Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):469-477. PubMed ID: 36961082
[TBL] [Abstract][Full Text] [Related]
4. Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study.
Seishima R; Okabayashi K; Ikeuchi H; Uchino M; Futami K; Noguchi T; Ohge H; Iseki Y; Watanabe K; Itabashi M; Okamoto K; Toiyama Y; Ogino T; Nakamura M; Yamada K; Wakai T; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Ishida F; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Yamamoto S; Hanai T; Maemoto A; Arakaki J; Komori K; Akagi Y; Shida D; Yamaguchi S; Matsuda K; Maeda K; Noake T; Nezu R; Sasaki S; Hasegawa J; Sunami E; Kanemitsu Y; Katsumata K; Uehara K; Kiyomatsu T; Suto T; Kazama S; Yamada T; Goi T; Ishihara S; Ajioka Y; Sugihara K
Am J Gastroenterol; 2023 Jul; 118(7):1248-1255. PubMed ID: 36622356
[TBL] [Abstract][Full Text] [Related]
5. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
[TBL] [Abstract][Full Text] [Related]
6. Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Gu P; Luo J; Kim J; Paul P; Limketkai B; Sauk JS; Park S; Parekh N; Zheng K; Rudrapatna V; Syal G; Ha C; McGovern DP; Melmed GY; Fleshner P; Eisenstein S; Ramamoorthy S; Dulai PS; Boland BS; Grunvald E; Mahadevan U; Ohno-Machado L; Sandborn WJ; Singh S
Am J Gastroenterol; 2022 Oct; 117(10):1639-1647. PubMed ID: 35973139
[TBL] [Abstract][Full Text] [Related]
7. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
[TBL] [Abstract][Full Text] [Related]
8. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
9. Abdominal pain is associated with an increased risk of future healthcare resource utilization in inflammatory bowel disease.
Zubrzycka I; Bogale K; Stuart A; Cesaire M; Walter V; Dalessio S; Tinsley A; Williams E; Clarke K; Coates MD
Int J Colorectal Dis; 2023 Aug; 38(1):213. PubMed ID: 37578543
[TBL] [Abstract][Full Text] [Related]
10. Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies.
Cai Q; Ding Z; Fu AZ; Patel AA
BMC Gastroenterol; 2022 Dec; 22(1):545. PubMed ID: 36581802
[TBL] [Abstract][Full Text] [Related]
11. Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score-matched analysis of US nationwide inpatient sample 2016-2018.
Zheng WW; Zhou Q; Xue ML; Yu X; Chen JT; Ao L; Wang CD
J Dig Dis; 2023 Nov; 24(11):572-583. PubMed ID: 37823607
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease.
Gordon BL; Galati JS; Yang S; Longman RS; Lukin D; Scherl EJ; Battat R
World J Gastroenterol; 2022 Sep; 28(33):4834-4845. PubMed ID: 36156920
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.
AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O
J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388
[TBL] [Abstract][Full Text] [Related]
14. Acute idiopathic pancreatitis is associated with more aggressive disease course in Crohn's disease but not in ulcerative colitis.
Osman KT; Hoque A; Pasam RT; Farhoud A; Abdelfattah A; Ramadorai V; Chaudrey K; Pellish R
BMC Gastroenterol; 2023 May; 23(1):171. PubMed ID: 37217857
[TBL] [Abstract][Full Text] [Related]
15. Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study.
Iacucci M; Jeffery L; Acharjee A; Grisan E; Buda A; Nardone OM; Smith SCL; Labarile N; Zardo D; Ungar B; Hunter S; Mao R; Cannatelli R; Shivaji UN; Parigi TL; Reynolds GM; Gkoutos GV; Ghosh S
Inflamm Bowel Dis; 2023 Sep; 29(9):1409-1420. PubMed ID: 36378498
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of Bowel Preparation and Colonoscopy in IBD Patients: Results From a Prospective, Single-Center, Case-Control Study.
Bezzio C; Schettino M; Manes G; Andreozzi P; Arena I; Della Corte C; Costetti M; Devani M; Omazzi BF; Saibeni S
Crohns Colitis 360; 2020 Oct; 2(4):otaa077. PubMed ID: 36777747
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
Barber GE; Hendler S; Choe M; Keyashian K; Lechner S; Limketkai BN; Limsui D
Dig Dis Sci; 2022 Apr; 67(4):1287-1294. PubMed ID: 33755823
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease in a colorectal cancer screening population: Diagnosis and follow-up.
Bezzio C; Manes G; Schettino M; Arena I; de Nucci G; Della Corte C; Devani M; Mandelli E; Morganti D; Omazzi B; Pellegrini L; Picascia D; Redaelli D; Reati R; Saibeni S
Dig Liver Dis; 2021 May; 53(5):587-591. PubMed ID: 32863160
[TBL] [Abstract][Full Text] [Related]
20. Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study.
Li J; Liu Z; Hu P; Wen Z; Cao Q; Zou X; Chen Y; Wang Y; Zhong J; Shen X; Demuth D; Fadeeva O; Xie L; Chen J; Qian J
BMC Gastroenterol; 2022 Feb; 22(1):44. PubMed ID: 35120446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
